AbSci Corporation (ABSI)

[ANTADOG]

they are tryin' some megalow vol shakes, but it will only come back stronger, don't make mistakes toyin' with a lowfloatah, fyi ANT

[ANTADOG]

a day range of 5,30 - 5,85 on an ordinary tradin' day, should give us a good idea how fast this would go when some test results get known, especially with insiders still willin' to buy, just fyi, ANT

[ANTADOG]

930k shares traded and more than one hour to go, we're gonna get our million shares again today, awesome, ANT

[ANTADOG]

500k shares after 90 minutes, intact, ANT

[ANTADOG]

8 bucks remains my first target, 52 wk high currently = 6,40, fyi ANT

[ANTADOG]

Gonna pass 250k shares volume in the first 30 minutes again, interest is here, heard the placement was overwritten in a big way, good, xcellent, ANT

[ANTADOG]

added some more 5,52's, ANT

[Monksdream]

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

[ANTADOG]

1 million shares traded, intact, ANT

[ANTADOG]

macd positive overall, current rsi daily 60, hold 'm tight, ANT

[ANTADOG]

2,5 mil shares traded, 5,83~~ this puppy is workin' his way up, ANT

[ANTADOG]

2 million shares traded with 2 hours to go, ANT

[Monksdream]

ABSI new 52 week high

[ANTADOG]

Nice volume out of the gate and a high of 6,40 so far, i kinda luv it, my options are doin' well, ANT

[ANTADOG]

6,25~~ ANT

[ANTADOG]

6,20~~ ANT

[ANTADOG]

gm, double digit stock eoy or sooner, ANT

[ANTADOG]

some future events:
https://investors.absci.com/news-and-events/events-and-presentations
fyi ANT

[Monksdream]

ABSI new 52 week high

[ANTADOG]

5,53~~ and a new 52wkhigh already, fyi ANT

[ANTADOG]

We're there, breakin' out of top, let's see, ANT

[ANTADOG]

almost there, push bb push, ANT

[ANTADOG]

5,39 ~~ headin' towards a new 52 wk high today? Stay tuned, ANT

[ANTADOG]

5,22~~ if u only knew who is holdin' shares... Hmm ANT

[ANTADOG]

5,20~~ ANT

[ANTADOG]

lookin' forward to gettin' a new 52 wk high, yup, ANT

[ANTADOG]

5,15 close, i kinda like it, ANT

[ANTADOG]

5,13~~ we're cruisin' fives, and i luv it, ANT

[ANTADOG]

5,50 is nxt imosho ANT

[ANTADOG]

5,02~~ ANT

[ANTADOG]

I luv the look of 5's in the mornin', ANT

[ANTADOG]

finally, ihub mega slow here today, ANT

[ANTADOG]

VANCOUVER, Wash., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, today announced the pricing of an underwritten public offering of 16,700,000 shares of its common stock at a public offering price of $4.50 per share, before deducting underwriting discounts and commissions. In addition, Absci has granted the underwriters a 30-day option to purchase up to an additional 2,505,000 shares of its common stock on the same terms and conditions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $75.2 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares in the offering are to be sold by Absci.

Absci intends to use the net proceeds from the offering to fund the development of its internal asset programs, continued investment in its Integrated Drug Creation™ platform, including related AI and wet-lab technologies, and for working capital and other general corporate purposes.

Morgan Stanley and TD Cowen are acting as joint book-running managers for the offering. The offering is expected to close on or about March 1, 2024, subject to the satisfaction of customary closing conditions.

The shares of common stock are being offered by Absci pursuant to an effective shelf registration statement on Form S-3 (File No. 333-267043) that was previously filed with the U.S. Securities and Exchange Commission (SEC) on August 24, 2022 and became effective on September 2, 2022. A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the offering was filed with the SEC on February 27, 2024. The final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and may be obtained, when available, from Morgan Stanley & Co LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by telephone: [phone], or by email at [e-mail]; Cowen and Company, LLC, 599 Lexington Avenue, New York, NY 10022, by telephone at [phone] or by email at [e-mail]; or by accessing the SEC’s website at www.sec.gov.

[ANTADOG]

5,03~~ ANT

[ANTADOG]

4,90~~ consolidatin' just under 5 bucks, i like it and healthy, ANT

[ANTADOG]

5,13~~ ANT

[ANTADOG]

gm, above 5 bucks pm, nice, ANT

[ANTADOG]

although probably not a 1 mil share day, still trades strong, double digit eoy = still have 100% to go, ANT

[ice trader]

Looking to get back in 4.60 we wil see 😊

[ANTADOG]

Added 4,88's, thx, ANT

[ANTADOG]

probably a fat finger premarket, happens, ANT

[ice trader]

???

[ANTADOG]

a 6,37 spike pm, ANT

[ice trader]

SBEV has potential too I know there so many out there.

[ice trader]

I think the upside potential in brchf is huge but Absi is great too headed for double digits imo.

[ice trader]

Nice picking up a few more myself

[ANTADOG]

Sure thing, btw i bought a couple of your brchf's, they had an update today, 20k starter, fyi ANT

[ice trader]

5.37 if this breaks 5.50 this will moon shot

[ANTADOG]

5,35~~ hod, ANT

[ANTADOG]

5,29~~ and volume intact, 1 mil served with more than 2,5 hours to go, ANT